Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.735 USD | +1.09% | -8.92% | +28.95% |
05-23 | Oppenheimer Adjusts Price Target on Viracta Therapeutics to $11 From $13, Maintains Outperform Rating | MT |
05-14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VIRACTA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +1.09% | -8.92% | +28.95% | -49.66% | - | 28.87M |
- Stock Market
- Equities
- VIRX Stock
- Charts Viracta Therapeutics, Inc.
- Relative Strength Chart